JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kocjan, G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kocjan, G
Journal of Clinical Pathology 2005;58:561-567
© 2005 BMJ Publishing Group Ltd & Association of Clinical Pathologists


REVIEW

BEST PRACTICE No 185

BEST PRACTICE No 185 Cytological and molecular diagnosis of lymphoma

G Kocjan

Correspondence to:
Dr G Kocjan
Department of Histopathology, Rockefeller Building, University College London, London WC 1E 6JJ, UK; g.kocjan{at}ucl.ac.uk
ABSTRACT
With the advances in molecular pathology, the cell as a morphological and functional unit has become essential in the diagnosis of lymphoma. Conventional staining, preparation, and interpretation of cells, as seen in fine needle aspiration cytology (FNAC), often used as a first line investigation of lymphadenopathy, is being supplemented with an array of immunocytochemical and molecular analyses, aimed not only at a more precise disease definition, but also at recognising factors that can predict prognosis and response to treatment. Accepting the pitfalls of conventional cytomorphology, this review looks at molecular changes characteristic to particular lymphomas and explores the currently available technology for their detection, with particular reference to cytological material. Future protocols for the diagnosis and management of patients with lymphadenopathy should include FNAC as an initial investigation, followed by immunocytochemistry and molecular investigations. Tissue biopsy, the conventional method of diagnosis, may be avoided in selected cases.


Abbreviations: ALCL, anaplastic large cell lymphoma; ALK, anaplastic lymphoma kinase; BL, Burkitt lymphoma; DLBL, diffuse large B cell lymphoma; FISH, fluorescence in situ hybridisation; FL, follicular lymphoma; FNAC, fine needle aspiration cytology; IgH, immunoglobulin heavy chain; MZL, mantle zone lymphoma; NHL, non-Hodgkin lymphoma; PCR, polymerase chain reaction

Keywords: fine needle aspiration cytology; lymphoma cytology; lymphoma diagnosis; molecular diagnosis cytology; molecular diagnosis of lymphoma




This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
L Venkatraman, M A Catherwood, A Patterson, T F Lioe, W G McCluggage, and N H Anderson
Role of polymerase chain reaction and immunocytochemistry in the cytological assessment of lymphoid proliferations
J. Clin. Pathol., November 1, 2006; 59(11): 1160 - 1165.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.